BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35908874)

  • 1. Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.
    Wu X; Wei X; Li X; Deng J; Zhang J
    Jpn J Infect Dis; 2022 Nov; 75(6):560-568. PubMed ID: 35908874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lung microbiome in moderate and severe chronic obstructive pulmonary disease.
    Pragman AA; Kim HB; Reilly CS; Wendt C; Isaacson RE
    PLoS One; 2012; 7(10):e47305. PubMed ID: 23071781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva as a non-invasive specimen for COPD assessment.
    Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A
    Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection.
    Morris A; Paulson JN; Talukder H; Tipton L; Kling H; Cui L; Fitch A; Pop M; Norris KA; Ghedin E
    Microbiome; 2016 Jul; 4(1):38. PubMed ID: 27391224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
    Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
    PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.
    Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R
    PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering microbial diversity associated with Fusarium wilt-diseased and disease-free banana rhizosphere soil.
    Zhou D; Jing T; Chen Y; Wang F; Qi D; Feng R; Xie J; Li H
    BMC Microbiol; 2019 Jul; 19(1):161. PubMed ID: 31299891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Conventional Culture and MALDI-TOF MS for Identification of Microbial Communities in Bronchoalveolar Lavage Fluid in Comparison with the GS Junior Next Generation Sequencing System.
    Sung JY; Hwang Y; Shin MH; Park MS; Lee SH; Yong D; Lee K
    Ann Lab Med; 2018 Mar; 38(2):110-118. PubMed ID: 29214754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diversity of fungal and bacterial communities in the marine sponge Dragmacidon reticulatum.
    Passarini MR; Miqueletto PB; de Oliveira VM; Sette LD
    J Basic Microbiol; 2015 Feb; 55(2):207-20. PubMed ID: 25213208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and variation of root-associated microbiomes of potato grown in alfisol.
    Mardanova A; Lutfullin M; Hadieva G; Akosah Y; Pudova D; Kabanov D; Shagimardanova E; Vankov P; Vologin S; Gogoleva N; Stasevski Z; Sharipova M
    World J Microbiol Biotechnol; 2019 Nov; 35(12):181. PubMed ID: 31728652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
    Opron K; Begley LA; Erb-Downward JR; Freeman C; Madapoosi S; Alexis NE; Barjaktarevic I; Graham Barr R; Bleecker ER; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper DJ; Doerschuk CM; Dransfield MT; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kaner RJ; Krishnan J; O'Neal WK; Ortega VE; Paine R; Peters SP; Michael Wells J; Woodruff PG; Martinez FJ; Curtis JL; Huffnagle GB; Huang YJ
    NPJ Biofilms Microbiomes; 2021 Feb; 7(1):14. PubMed ID: 33547327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
    J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ; Boushey HA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD.
    Su J; Liu HY; Tan XL; Ji Y; Jiang YX; Prabhakar M; Rong ZH; Zhou HW; Zhang GX
    PLoS One; 2015; 10(7):e0130736. PubMed ID: 26147303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.